Pharmaceutical Company Defense Lawyers Health Care Fraud Federal False Claims Act 31 USC 3729

Pharmaceutical Company Defense Lawyers Health Care Fraud Federal False Claims Act 31 USC 3729Are you a pharmaceutical company with federal government contracts facing potential False Claims Act (FCA) allegations ( 31 USC 3729 – 3733) , from the OIG or DOJ?  Are You Looking for Defense Attorneys for Pharmaceutical Companies in Federal False Claims Act Cases?

With the right defense lawyers who understand the complex federal procurement rules, you can push back and position the company for more favorable results.  At Watson. & Associates, LLC, we understand the complexity of such legal challenges and have a team of defense attorneys focusing on pharmaceutical False Claims Act defense cases.

We also represent companies seeking professional help with manufacturing products that are directly or indirectly to the federal government. The law firm can help you navigate these intricate waters of federal procurement, addressing your concerns and resolving your problems effectively.

Pharmaceutical Company Health Care Fraud 31 USC 3729 Investigations and Trial Litigation Support

When the Department of Justice (DOJ), OIG, SEC or other federal investigative agencies get involved with civil or criminal health care fraud cases involving pharmaceutical companies, our defense lawyers aggressively represent corporations and CEOs facing investigation or indictments by a federal grand jury.

When a Medicare beneficiary obtains a prescription drug covered by Medicare Part D, the beneficiary may be required to make a partial payment, which may take the form of a copayment, coinsurance, or a deductible (collectively “copays”). Congress included copay requirements in the Medicare program, in part, to encourage market forces to serve as a check on health care costs, including the prices that pharmaceutical manufacturers can demand for their drugs. Under the Anti-Kickback Statute, a pharmaceutical company is prohibited from offering, directly or indirectly, any remuneration — which includes paying patients’ copay obligations — to induce Medicare patients to purchase the company’s drugs.

Watson & Associates, Pharmaceutical False Claims Act attorneys are positioned to aggressively defend clients  federal False Claims Act investigations and litigations on behalf of government contractors, health care providers, manufacturers of pharmaceuticals and medical devices, commercial companies and financial institutions. We can represent clients in Health Care Fraud False Claims Act investigations and litigations nationwide, including in California, the District of Columbia, Florida, Georgia, Idaho, Kentucky, Illinois, Massachusetts, Minnesota, Missouri, New Mexico, Nevada, New York, Ohio, Tennessee, Texas, and Virginia. We also have extensive experience defending criminal and administrative investigations and litigation, which often accompany False Claims Act Investigations. Our experience includes:

  • Civil, criminal, and administrative investigative subpoenas
  • Grand jury investigations
  • Search warrants
  • Civil Investigative Demands (or “CIDs”)
  • False Claims Act litigation – including government initiated and qui tam whistleblower actions – throughout the country
  • False Claims Act jury and bench trials
  • Suspension, debarment, and program exclusion proceedings

Trade Agreements Act (TAA Compliance) Help for Pharmaceutical Companies

Pharmaceutical companies sometimes are challenged regarding ther compliance with the Trade Agreement Act requirements. When those companies manufacture, resell or sell indirectly to the federal government, our government contract procurement lawyers help companies to reassess their internal controls and policies in addition to representing those pharmaceutical companies during Trade Agreements Act false claims act fraud investigations related to non-TAA compliance. Our 31 USC 3729 pharmaceutical lawyers are ready and here to help.

Key Benefits of Choosing Watson & Associates, LLC’s Pharmaceutical Company. Defense Lawyers

  1. Proven Expertise: Our pharmaceutical defense lawyers focus on defending FCA cases, ensuring you receive the expertise you need.
  2. Focus on resolution without trial:  We strongly believe that we should not go to trial if we absolutely have to. When the OIG or DOJ issues a civil investigative demand or subpoena, we take it from there and immediately look to prepare a legal defense to the allegations right away. of successfully defending pharmaceutical companies against 31. USC 3729 FCA allegations, saving them millions of dollars in potential fines and penalties.
  3. Government Contract Expertise: Our team possesses in-depth knowledge of federal government contracts (30-plus years) and the intricacies of FCA regulations, giving you targeted legal advice.
  4. Legal Problem Solvers: As pharmaceutical company defense attorneys, we are committed to efficiently resolving your legal issues, helping you maintain your reputation and focus on your core business activities.

GET A FREE COPY OF YOUR FALSE CLAIMS ACT DEFENSE CHECKLIST HERE

Common Concerns Addressed:

  1. What is the False Claims Act (FCA)? The False Claims Act (FCA) is a federal law that imposes liability on individuals and entities for submitting false or fraudulent claims to the government. Pharmaceutical companies with government contracts can be particularly vulnerable to FCA investigations.
  2. How can Watson & Associates help? Our FCA defense attorneys have a comprehensive understanding of False Claims Act regulations and the pharmaceutical industry. We will work closely with your team to assess the allegations, develop a robust defense strategy, and negotiate on your behalf with government authorities.
  3. Will FCA allegations affect my government contracts? FCA allegations can jeopardize your government contracts and lead to severe financial repercussions. We will help you mitigate these risks, protect your contracts, and maintain your reputation in the industry.
  4. What sets Watson & Associates law firm apart from other law firms? Our firm’s unique expertise in government contract knowledge, and the ability to solve high-level problems, positions us as the ideal choice for pharmaceutical companies facing such challenges.

Contact our pharmaceutical company defense lawyers for immediate help

If you have received a civil investigative demand (CID)under 31 USC 3729 or subpoena in a federal procurement case, please call our pharmaceutical company defense lawyers at 1.866.601.5518. Speak to Lead Counsel Theodore Watson for immediate help.